Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2008
10/09/2008US20080248025 Gamma Delta T Cells and Methods of Treatment of Interleukin-17 Related Conditions
10/09/2008US20080248024 Using oligonucleotides specific to zinc finger protein 91 (ZFP91) as therapeutic inhibitors in treatment of cell proliferative, inflammatory and gastrointestinal disorders; RNA interference
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248019 Hydrolase which utilizes linkage-specific cleavage of galactose as part of therapeutic regimen for treatment of cell proliferative disorders; antitumor agents
10/09/2008US20080248018 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders
10/09/2008US20080248009 Using antisense agents specific to apoptosis-associated nucleic acids to modulate apoptosis in transplanted tissues; treating cell proliferative disorders
10/09/2008US20080248004 Bone marrow and/or cord stem cell culture for use in treatment of nervous system disorders; tissue engineering and repair; regenerative medicine
10/09/2008US20080248002 Cytokine induced killer cell populations for use in treatment of cell proliferative disordersl; tissue engineering and repair; tissue targeted therapy
10/09/2008US20080248001 Methods and systems for treating cell proliferation disorders
10/09/2008US20080247999 Cyclin dependent kinase-4 (CDK-4) peptides for use in treatment of cell proliferative disorders; antitumor agents
10/09/2008US20080247996 Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation
10/09/2008US20080247994 DNA vaccine
10/09/2008US20080247953 Drug screening assays; SH2 docking domains; signal sequences; immunology; cyclophilins
10/09/2008US20080247950 Proteases of human kallikrein 2 (hK2); tissue imaging
10/09/2008CA2702305A1 Cancer cell targeting using nanoparticles
10/09/2008CA2683938A1 Water soluble opuntia extracts for the inhibition of alpha-1-adrenergic receptors
10/09/2008CA2683370A1 Cross-species-specific binding domain
10/09/2008CA2682851A1 A novel antigen associated with the neovasculature of tumour metastases
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682622A1 Amidation process for the preparation of cathepsin k inhibitors
10/09/2008CA2682567A1 Non-peptidic molecules for detecting and treating tumors
10/09/2008CA2682521A1 Methods and compositions for the treatment of proliferative diseases
10/09/2008CA2682493A1 Targeting agent for cancer cell or cancer-associated fibroblast
10/09/2008CA2682483A1 3-imidazolyl-indoles for the treatment of proliferative diseases
10/09/2008CA2682384A1 Benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/09/2008CA2682382A1 Non-fucosylated antibodies
10/09/2008CA2682266A1 Treatment of hodgkins lymphoma
10/09/2008CA2682231A1 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
10/09/2008CA2682093A1 Antibodies, methods and kits for diagnosing and treating melanoma
10/09/2008CA2681790A1 Composition of labeled and non-labeled monoclonal antibodies
10/09/2008CA2681756A1 Inhibitors of bruton's tyrosine kinase
10/09/2008CA2681712A1 Tamibarotene capsule preparation
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1978097A1 Regulation of transcription factor, NF-IL6/LAP
10/08/2008EP1978096A1 Novel oligonucleotide and nf-kappa b decoy comprising the same
10/08/2008EP1978034A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1977765A1 Peptide prodrugs
10/08/2008EP1977760A2 Method for Treating Cervical Cancer
10/08/2008EP1977753A1 Combined preparation comprising anthracycline derivatives
10/08/2008EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/08/2008EP1977741A2 Use of renin inhibitors in therapy
10/08/2008EP1976987A1 Novel cancer-associated antigen
10/08/2008EP1976883A2 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008EP1976839A2 Compounds and methods for modulating protein trafficking
10/08/2008EP1976564A2 Immuno-rna-constructs
10/08/2008EP1976550A2 Identification of apoptosis inducing proteins
10/08/2008EP1976545A1 Anticancer agent comprising a peptide
10/08/2008EP1976542A1 Therapeutic use of an extract from the leaves of nerium oleander
10/08/2008EP1976540A1 Treatment substance containing magnesium salts for treatment of tumors or like and use of magnesium salts
10/08/2008EP1976539A2 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents
10/08/2008EP1976533A2 Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
10/08/2008EP1976531A1 Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
10/08/2008EP1976530A1 Combination of mtor inhibitor and antipolate compound
10/08/2008EP1976529A2 Ang2 and vegf inhibitor combinations
10/08/2008EP1976528A2 Prokineticin 2 receptor antagonists
10/08/2008EP1976505A1 Combretastatin derivatives and related therapeutic methods
10/08/2008EP1824863B1 Silicon compounds and their use
10/08/2008EP1606283B1 P38 inhibitors and methods of use thereof
10/08/2008EP1583522B1 Use of cyclin d1 inhibitors for breast cancer treatment
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1370298B1 Elongated and multiple spacers in activatible prodrugs
10/08/2008EP1349870B1 Compositions for the therapy and diagnosis of ovarian cancer
10/08/2008EP1320589B1 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
10/08/2008EP1262548B1 Polypeptide inducing apoptosis
10/08/2008EP1189626B1 Composition for preventing tumoral growth
10/08/2008EP1157105B8 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
10/08/2008EP1064298B1 Inhibitors of caspases
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008EP0804580B1 Calcium binding recombinant antibody against protein c
10/08/2008CN101283279A Screening and therapeutic method for nsclc targeting CDCA1-KNTC2 complex
10/08/2008CN101282994A Anti-CD26 antibodies and methods of use thereof
10/08/2008CN101282993A Antibodies directed to cd20 and uses thereof
10/08/2008CN101282975A Compounds and compositions as protein kinase inhibitors
10/08/2008CN101282960A RAF inhibitor compounds and methods
10/08/2008CN101282955A Crystalline forms of docetaxel and processes for their preparation
10/08/2008CN101282946A 新的半胱氨酸蛋白酶抑制剂及它们的治疗应用 The new cysteine ​​protease inhibitors and their therapeutic applications
10/08/2008CN101282935A Isoquinolines derivatives as IGF-1R inhibitors
10/08/2008CN101282761A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101282745A B-cell reduction using CD37-specific and CD20-specific binding molecules
10/08/2008CN101282742A Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
10/08/2008CN101282728A Combination of organic compounds
10/08/2008CN101280318A Recombinant human HNP gene liposome complex, preparation and use thereof
10/08/2008CN101280317A FAK and EGFR targeted RNA interference plasmid-lipidosome antineoplastic complex
10/08/2008CN101280288A Space efficient microbial strain of 20th recoverable satellite, preparation and application thereof
10/08/2008CN101280287A Space efficient microbial strain of 21st recoverable satellite, preparation and application thereof
10/08/2008CN101280286A Space efficient microbial strain of 22nd recoverable satellite, preparation and application thereof
10/08/2008CN101280026A Use of polysaecharide from the eggs of strongylocentrotus nudus with alpha-1,4-dextran chain
10/08/2008CN101280025A Antitumaous echinus shell polysaccharide and preparation thereof
10/08/2008CN101280014A Anti-Cyclin D1 human single-chain antibody
10/08/2008CN101280004A Polypeptide ERC(N5) for specific inhibition of tumor cell and tumor angiogenic blood vessel
10/08/2008CN101279995A Tripterine salt, preparation and use thereof
10/08/2008CN101279993A 3-aryl-8-hydroxychromone-7-O-alpha-D-arabinofuranoside compound, synthetic method and use thereof
10/08/2008CN101279983A 抗肿瘤联合药物 Joint anti-tumor drugs
10/08/2008CN101279967A Medicinal composition of trimethyl xanthone-4-acetic acid for treating cancer and use thereof
10/08/2008CN101279956A Matrix metalloprotease inhibitors and synthetic method thereof
10/08/2008CN101279927A Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
10/08/2008CN101279915A Substituted phenol and application thereof as receptor TR3 excitant
10/08/2008CN101279093A Cancer modulation antibody
1 ... 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 ... 2211